{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:14:26Z","timestamp":1787375666546,"version":"build-2736575974"},"reference-count":139,"publisher":"Elsevier","isbn-type":[{"value":"9780443431708","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.vh.2025.08.006","type":"book-chapter","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:33:58Z","timestamp":1765802038000},"page":"151-193","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis of primary aldosteronism: Novel workup strategies and biochemical tools"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0373-1573","authenticated-orcid":false,"given":"Arturo","family":"Vega-Beyhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Jimenez-Casinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2025.08.006_bib0001","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","article-title":"Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study","volume":"16","author":"Abdelhamid","year":"2003","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0002","first-page":"1","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"00","author":"Adler","year":"2025","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-57427-7","article-title":"Application of CT texture analysis to assess the localization of primary aldosteronism","volume":"10","author":"Akai","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2025.08.006_bib0057","article-title":"Urinary metabolic signature of primary aldosteronism: Gender and subtype-specific alterations","volume":"13","author":"Alessandro","year":"2019","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/bs.vh.2025.08.006_bib0112","first-page":"16","article-title":"Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics","author":"Alicja","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12020-020-02544-6","article-title":"Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review","volume":"72","author":"Araujo-Castro","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0004","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/biomedicines11071934","article-title":"Diagnostic accuracy of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for the subtyping of primary aldosteronism","volume":"11","author":"Araujo-Castro","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/bs.vh.2025.08.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/bs.vh.2025.08.006_bib0097","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/MNM.0000000000001293","article-title":"131I-6\u03b2-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism","volume":"41","author":"Atsushi","year":"2020","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/bs.vh.2025.08.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab032","article-title":"Proteomic profile of urinary extracellular vesicles identifies agp1 as a potential biomarker of primary aldosteronism","volume":"162","author":"Barros","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0008","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4155\/bio-2016-0115","article-title":"Determination of urinary aldosterone using a plasma aldosterone 2D ID LC-MS\/MS method","volume":"8","author":"Bekkach","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.vh.2025.08.006_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1096441","article-title":"Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism","volume":"14","author":"Bertolone","year":"2023","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0012","article-title":"Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism","volume":"105","author":"Burrello","year":"2020","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of 11c-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas","volume":"97","author":"Burtonm","year":"2012","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/bs.vh.2018.09.002","article-title":"Regulation of aldosterone signaling by Micrornas","volume":"109","author":"Butterworth","year":"2019","journal-title":"Vitamins and Hormone"},{"key":"10.1016\/bs.vh.2025.08.006_bib0016","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clinical Chemistry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/eje.1.02164","article-title":"Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites","volume":"154","author":"Caroline","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768734","article-title":"Serum alpha-1-acid glycoprotein-1 and urinary extracellular vesicle mir-21-5p as potential biomarkers of primary aldosteronism","volume":"12","author":"Carvajal","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0018","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0034-1374638","article-title":"The role of urinary aldosterone for the diagnosis of primary aldosteronism","volume":"46","author":"Ceral","year":"2014","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0019","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41440-023-01347-2","article-title":"Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC\u2013MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol","volume":"46","author":"Chang","year":"2023","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/jch.70062","article-title":"LC-MS\/MS-Based assay for steroid profiling in peripheral and adrenal venous samples for the subtyping of primary aldosteronism","volume":"27","author":"Chen","year":"2025","journal-title":"The Journal of Clinical Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.acra.2023.10.015","article-title":"Machine learning model with computed tomography radiomics and clinicobiochemical characteristics predict the subtypes of patients with primary aldosteronism","volume":"31","author":"Chen","year":"2024","journal-title":"Academic Radio"},{"key":"10.1016\/bs.vh.2025.08.006_bib0022","first-page":"37","article-title":"Simultaneous quantitation of urine aldosterone and tetrahydroaldosterone in healthy Chinese subjects using a validated LC\u2013MS\/MS method","author":"Cheng","year":"2023","journal-title":"Biomedical Chromatography"},{"key":"10.1016\/bs.vh.2025.08.006_bib0064","article-title":"Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio","author":"Clara Wai-Shan","year":"2025","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0023","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/HYPERTENSIONAHA.124.23029","article-title":"Steroidomics-based screening for primary aldosteronism: impact of antihypertensive drugs","volume":"81","author":"Constantinescu","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0024","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1515\/cclm-2022-0470","article-title":"Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism","volume":"60","author":"Constantinescu","year":"2022","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/jcem-36-4-756","article-title":"Urinary free aldosterone in healthy people and in patients with primary aldosteronism","volume":"36","author":"Deck","year":"1973","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA expression profiling in primary aldosteronism","author":"Decmann","year":"2019","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0028","doi-asserted-by":"crossref","unstructured":"Ding, J., Zhang, Y., Wen, J., Zhang, H., Wang, H., Luo, Y., Pan, Q., Zhu, W., Wang, X., Yao, S., Kreissl, M.C., Hacker, M., Anli Tong, A., Huo, L., Li, X. (2020). Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. European Journal of Nuclear Medicine and Molecular Imaging, 7, 2656\u20132665. 10.1007\/S00259-020-04722-0\/FIGURES\/4.","DOI":"10.1007\/s00259-020-04722-0"},{"key":"10.1016\/bs.vh.2025.08.006_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.123.266061","article-title":"Clinical value of 68Ga-Pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules","volume":"65","author":"Ding","year":"2024","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0030","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/bs.vh.2025.08.006_bib0031","doi-asserted-by":"crossref","first-page":"E2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0029","doi-asserted-by":"crossref","unstructured":"Eisenhofer, G., Dekkers, T., Peitzsch, M., Anna S Dietz, A.S., Bidlingmaier, M., Treitl, M., Williams, T.A., Bornstein, S.R., Haase, M., Rump, L.C., Willenberg, H.S., Beuschlein, F., Deinum, J., Lenders, J.W.M., Reincke, M. (2016). Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clinical Chemistry, 62, 514\u2013524. 10.1373\/clinchem.2015.251199.","DOI":"10.1373\/clinchem.2015.251199"},{"key":"10.1016\/bs.vh.2025.08.006_bib0048","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/diagnostics10080545","article-title":"Aldosterone-mediated sodium retention is reflected by the serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (susppup) index","volume":"10","author":"Evelien","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/bs.vh.2025.08.006_bib0086","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41440-021-00710-5","article-title":"Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism","volume":"44","author":"Fumika","year":"2021","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0032","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0033","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","article-title":"Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET\/CT","volume":"33","author":"Gao","year":"2023","journal-title":"European Radiology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112240","article-title":"Performance of pentixafor pet\/ct in identifying unilateral primary aldosteronism: a meta-analysis","volume":"190","author":"Gege","year":"2025","journal-title":"European Journal of Radiology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0038","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/clinchem\/hvaa001","article-title":"Measurement of equilibrium angiotensin ii in the diagnosis of primary aldosteronism","volume":"66","author":"Guo","year":"2020","journal-title":"Clinical Chemistry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0034","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.eprac.2025.02.012","article-title":"Primary aldosteronism classification with 18-oxocortisol and gallium-68\u2013pentixafor positron emission tomography\/computed tomography","volume":"31","author":"Gao","year":"2025","journal-title":"Endocrine Practice"},{"key":"10.1016\/bs.vh.2025.08.006_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1335329","article-title":"Increased daytime and awakening salivary free aldosterone in essential hypertensive men","volume":"11","author":"Gideon","year":"2024","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0037","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1440-1681.1986.tb00357.x","article-title":"Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumour pre-operatively","volume":"13","author":"Gordon","year":"1986","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0042","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0052","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","article-title":"Development and validation of subtype prediction scores for the workup of primary aldosteronism","volume":"36","author":"Hiroki","year":"2018","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0043","doi-asserted-by":"crossref","first-page":"1621S","DOI":"10.1093\/jn\/131.5.1621S","article-title":"Human saliva as a diagnostic specimen","volume":"131","author":"Hofman","year":"2001","journal-title":"Journal of Nutrition"},{"key":"10.1016\/bs.vh.2025.08.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography\u2013computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/bs.vh.2025.08.006_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032070","article-title":"Clinical diagnostic value of liquid chromatography-tandem mass spectrometry method for primary aldosteronism in patients with hypertension: a systematic review and meta-analysis","volume":"13","author":"Hua","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-angiotensin-aldosterone system triple-a analysis for the screening of primary aldosteronism","volume":"75","author":"Jacopo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0013","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.17136","article-title":"Characterization of circulating extracellular vesicle surface antigens in patients with primary aldosteronism","volume":"78","author":"Jacopo","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0047","first-page":"12","article-title":"Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit","volume":"ONE,","author":"J\u0119drusik","year":"2017","journal-title":"PLoS"},{"key":"10.1016\/bs.vh.2025.08.006_bib0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cen.12814","article-title":"Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH","volume":"83","author":"Juan","year":"2015","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-29653-2","article-title":"A hyperaldosteronism subtypes predictive model using ensemble learning","volume":"13","author":"Karashima","year":"2023","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2025.08.006_bib0050","doi-asserted-by":"crossref","first-page":"bvaa100","DOI":"10.1210\/jendso\/bvaa100","article-title":"Reassessment of urinary aldosterone measurement after saline infusion in primary aldosteronism","volume":"4","author":"Kaneko","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/bs.vh.2025.08.006_bib0049","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cen.14111","article-title":"Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism","volume":"91","author":"Kaneko","year":"2019","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0082","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s12020-015-0615-9","article-title":"Shortened saline infusion test for subtype prediction in primary aldosteronism","volume":"50","author":"Kazutaka","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0044","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1507\/endocrj.EJ24-0227","article-title":"Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan","volume":"71","author":"Ken-Ichiro","year":"2024","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2025.08.006_bib0053","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1507\/endocrj.EJ22-0585","article-title":"Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism","volume":"70","author":"Kobayashi","year":"2023","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2025.08.006_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12112806","article-title":"Validation of existing clinical prediction tools for primary aldosteronism subtyping","volume":"12","author":"Kolo\u0161ov\u00e1","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/bs.vh.2025.08.006_bib0054","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0009-9120(94)90030-2","article-title":"Monoclonal antibodies specific for 18-hydroxycortisol and their use in an enzyme immunoassay for human urinary 18-hydroxycortisol for diagnosis of primary aldosteronism","volume":"27-4","author":"Kohno","year":"1994","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0056","doi-asserted-by":"crossref","DOI":"10.2174\/0118715303361250250119035029","article-title":"Integrative analysis of metabolomic and transcriptomic data reveals metabolic signatures and major metabolic pathways in primary aldosteronism","volume":"25","author":"Lai","year":"2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/bs.vh.2025.08.006_bib0059","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clinms.2018.06.002","article-title":"Migration from ria to lc-ms\/ms for aldosterone determination: implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy belgian subjects","volume":"9","author":"Le Goff","year":"2018","journal-title":"Clinical Mass Spectrometry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12051124","article-title":"Poor performance of angiotensin ii enzyme-linked immuno-sorbent assays in mostly hypertensive cohort routinely screened for primary aldosteronism","volume":"12","author":"\u0141ebek-Szata\u0144ska","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/bs.vh.2025.08.006_bib0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0042-114037","article-title":"The clinical value of salivary aldosterone in diagnosis and follow-up of primary aldosteronism","volume":"48","author":"Lichtenauer","year":"2016","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0041","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.7150\/thno.100848","article-title":"[18F]AlF-NOTA-pentixather PET\/CT of CXCR4 in patients with suspected primary hyperaldosteronism","volume":"14","author":"Limeng","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/bs.vh.2025.08.006_bib0063","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/CM9.0000000000001906","article-title":"Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: a meta-analysis","volume":"135","author":"Liu","year":"2022","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/bs.vh.2025.08.006_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.882148","article-title":"Online prediction model for primary aldosteronism in patients with hypertension in chinese population: a two-center retrospective study","volume":"13","author":"Lin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0062","first-page":"972","article-title":"Validating machine learning models against the saline test gold standard for primary aldosteronism diagnosis","volume":"4","author":"Liu","year":"2024","journal-title":"JACC: Asia"},{"key":"10.1016\/bs.vh.2025.08.006_bib0072","doi-asserted-by":"crossref","first-page":"1244342","DOI":"10.3389\/fendo.2023.1244342","article-title":"Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism","volume":"14","author":"Mansour","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0073","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/HYPERTENSIONAHA.124.22884","article-title":"Comparing ARR versus suppressed PRA as screening tests for primary aldosteronism","volume":"81","author":"Marcelli","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0087","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.119.13388","article-title":"AT1AA (Angiotensin ii type-1 receptor autoantibodies): cause or consequence of human primary aldosteronism?","volume":"74","author":"Maria","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0074","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1203\/00006450-197906000-00007","article-title":"The biologic significance of the aldosterone concentration in saliva","volume":"13","author":"McVie","year":"1979","journal-title":"Pediatric Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0071","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.steroids.2009.05.006","article-title":"Saliva as a medium for aldosterone measurement in repeated sampling studies","volume":"74","author":"Manolopoulou","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/bs.vh.2025.08.006_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215312","article-title":"Circulating micrornas as diagnostic markers in primary aldosteronism","volume":"13","author":"MacKenzie","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1511096","article-title":"Serum microRNAs as peripheral markers of primary aldosteronism","volume":"16","author":"Makhnov","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0069","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-025-04302-y","article-title":"Searching for peripheral proteomic markers of primary aldosteronism","author":"Makhnov","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0030-1248287","article-title":"Salivary aldosterone as a diagnostic aid in primary aldosteronism","volume":"42","author":"Manolopoulou","year":"2010","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0066","first-page":"137","volume":"124","author":"MacKenzie","year":"2024","journal-title":"MicroRNAs in aldosterone production and action. Vitamins and Hormones"},{"key":"10.1016\/bs.vh.2025.08.006_bib0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1311989","article-title":"Association of urinary sodium and potassium excretion with blood pressure","volume":"371","author":"Mente","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0076","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03348648","article-title":"Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism","volume":"15","author":"Miyamori","year":"1992","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/bs.vh.2025.08.006_bib0077","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low-renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0078","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0080","article-title":"18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism","volume":"96","author":"Nakamura","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0081","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/jhh.2014.20","article-title":"A subtype prediction score for primary aldosteronism","volume":"28","author":"Nanba","year":"2014","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0083","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2025.08.006_bib0085","doi-asserted-by":"crossref","unstructured":"Ng, E., Gwini, S.M., Zheng, W., Fuller, P.J., Yang, J. (2025). Tools to predict unilateral primary aldosteronism and optimise patient selection for adrenal vein sampling: a systematic review. Clinical Endocrinology, 103, 3. 10.1111\/CEN.15225.","DOI":"10.1111\/cen.15225"},{"key":"10.1016\/bs.vh.2025.08.006_bib0084","doi-asserted-by":"crossref","unstructured":"Ng, E., Gwini, S.M., Libianto, R., Choy, K.W., Lu, Z.X., Shen, J., Doery, J.C.G., Fuller, P.J., Yang, J. (2023). Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 108, 33\u201341. 10.1210\/clinem\/dgac568.","DOI":"10.1210\/clinem\/dgac568"},{"key":"10.1016\/bs.vh.2025.08.006_bib0088","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HJH.0000000000001168","article-title":"Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism","volume":"35","author":"Pizzolo","year":"2017","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106445","article-title":"Urine steroid metabolomics as a diagnostic tool in primary aldosteronism","volume":"237","author":"Prete","year":"2024","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0090","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/HJH.0000000000003132","article-title":"11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial","volume":"40","author":"Puar","year":"2022","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0091","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/bi00883a023","article-title":"Biosynthesis of C-18-oxygenated steroids by an aldosterone-secreting human adrenal tumor.* Metabolism of [4-14C] progesterone, [1,2-3H] 11-Deoxycorticosterone, and [4-14C]pregnenolone","volume":"4","author":"Raman","year":"1965","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0093","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0092","doi-asserted-by":"crossref","unstructured":"Reel, P.S., Reel, S., van Kralingen, J.C., Langton, K., Lang, K., Erlic, Z., ..., Reincke, M., et al. (2022). Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data-driven study. EBioMedicine, 84. 10.1016\/J.EBIOM.2022.104276.","DOI":"10.1016\/j.ebiom.2022.104276"},{"key":"10.1016\/bs.vh.2025.08.006_bib0094","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1530\/eje.1.01922","article-title":"The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism","volume":"152","author":"Reynolds","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0096","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","article-title":"MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex","volume":"62","author":"Robertson","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0095","first-page":"2","article-title":"Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma primary aldosteronism","volume":"61","author":"Ro","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0098","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0099","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0101","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41440-021-00663-9","article-title":"Urinary sodium\/potassium ratio as a screening tool for hyperaldosteronism in men with hypertension","volume":"44","author":"Segawa","year":"2021","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0102","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1210\/js.2018-00135","article-title":"GC\/MS in recent years has defined the normal and clinically disordered steroidome: will it soon be surpassed by LC\/Tandem MS in this role?","volume":"2","author":"Shackleton","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/bs.vh.2025.08.006_bib0103","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-025-04322-8","article-title":"Enhanced detection of primary aldosteronism in hypertensive patients with obstructive sleep apnea using a novel diagnostic algorithm","author":"Shah","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0104","doi-asserted-by":"crossref","first-page":"1005934","DOI":"10.3389\/fendo.2022.1005934","article-title":"A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism","volume":"13","author":"Shi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41440-021-00787-y","article-title":"Is the cut off point proper in screening of primary aldosteronism by urinary Na\/K ratio. Japanese are still high in Na\/K ratio","volume":"45","author":"Shimosawa","year":"2022","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0106","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5855","article-title":"Untargeted metabolomics reveals potential plasma biomarkers for diagnosis of primary aldosteronism using liquid chromatography\u2013mass spectrometry","volume":"38","author":"Song","year":"2024","journal-title":"Biomedical Chromatography"},{"key":"10.1016\/bs.vh.2025.08.006_bib0108","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215582","article-title":"Transcriptomics, epigenetics, and metabolomics of primary aldosteronism","volume":"13","author":"Spyroglou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.vh.2025.08.006_bib0109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2362.2010.02401.x","article-title":"Assessment of serum sodium to urinary sodium divided by (serum potassium)2 to urinary potassium as a screening tool for primary aldosteronism","volume":"41","author":"Steichen","year":"2011","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2025.08.006_bib0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.08.006_bib0107","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/HJH.0000000000003197","article-title":"Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism","volume":"40","author":"Song","year":"2022","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0111","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.124.23817","article-title":"ATP2A3 in primary aldosteronism: machine learning-based discovery and functional validation","volume":"82","author":"Sun","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0114","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40292-022-00523-8","article-title":"Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling","volume":"29","author":"Tamaru","year":"2022","journal-title":"High Blood Pressure and Cardiovascular Prevention"},{"key":"10.1016\/bs.vh.2025.08.006_bib0115","first-page":"1","article-title":"Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis","author":"Tang","year":"2025","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.vh.2025.08.006_bib0116","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12020-022-03103-x","article-title":"Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess","volume":"77","author":"Tapia-Castillo","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.08.006_bib0117","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41371-020-00465-5","article-title":"Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism","volume":"36","author":"Teruyama","year":"2022","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0118","doi-asserted-by":"crossref","first-page":"E3969","DOI":"10.1210\/clinem\/dgab420","article-title":"ACTH stimulation maximizes the accuracy of peripheral steroid profiling in primary aldosteronism subtyping","volume":"106","author":"Tezuka","year":"2021","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0120","doi-asserted-by":"crossref","unstructured":"Turcu, A.F., Wannachalee, T., Tsodikov, A., Nanba, A.T., Ren, J., Shields, J.J., O'Day, P.J., Giacherio, D., Rainey, W.E., Richard J Auchus, R.J. (2020). Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping. Hypertension, 75, 183\u2013192. 10.1161\/HYPERTENSIONAHA.119.13866.","DOI":"10.1161\/HYPERTENSIONAHA.119.13866"},{"key":"10.1016\/bs.vh.2025.08.006_bib0119","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70081","article-title":"Proteomic signatures to detect unilateral primary aldosteronism in hypertensive patients","author":"Tsai","year":"2025","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2025.08.006_bib0121","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/jcem-21-9-1092","article-title":"A comparison of methods for the acid hydrolysis of a urinary conjugate of aldosterone","volume":"21","author":"Underwood","year":"1961","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0122","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome:updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.08.006_bib0123","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism:state-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0124","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/HYPERTENSIONAHA.124.23418","article-title":"Circulating miRNAs and machine learning for lateralizing primary aldosteronism","volume":"81","author":"V\u00e9kony","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0125","doi-asserted-by":"crossref","unstructured":"Velema, M.S., Canu, L., Dekkers, T., Hermus, A.R.M.M., Timmers, H.J.L.M., Schultze, L.j., Kool,Groenewoud, H.J.M.M., Jacobs, C., Deinum, J. (2021). Volumetric evaluation of CT images of adrenal glands in primary aldosteronism. Journal of Endocrinological Investigation, 44, 2359\u20132366. 10.1007\/S40618-021-01540-5\/FIGURES\/3.","DOI":"10.1007\/s40618-021-01540-5"},{"key":"10.1016\/bs.vh.2025.08.006_bib0126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2008.02060.x","article-title":"The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism","volume":"39","author":"Willenberg","year":"2009","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2025.08.006_bib0127","first-page":"8","article-title":"Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism","volume":"ONE,","author":"Wu","year":"2013","journal-title":"PLoS"},{"key":"10.1016\/bs.vh.2025.08.006_bib0128","doi-asserted-by":"crossref","unstructured":"Wu, X., Senanayake, R., Goodchild, E., Bashari, W.A., Salsbury, J., Cabrera, C.P., ..., Eva Wozniak, E., (2023). [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism:a prospective, within-patient trial. Nature Medicine, 29, 190\u2013202. https:\/\/doi.org\/10.1038\/S41591-022-02114-5.","DOI":"10.1038\/s41591-022-02114-5"},{"key":"10.1016\/bs.vh.2025.08.006_bib0131","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/clinchem\/hvad065","article-title":"A novel enzymatic hydrolysis method for urine aldosterone quantification: a case for reassessing clinical cut-offs of primary aldosteronism","volume":"69","author":"Yazdanpanah","year":"2023","journal-title":"Clinical Chemistry"},{"key":"10.1016\/bs.vh.2025.08.006_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117325","article-title":"Reference intervals for LC-MS \/MS measurements of plasma renin activity, aldosterone, angiotensin II, and 24-hour urinary aldosterone in Northern Chinese Han population","volume":"543","author":"Yin","year":"2023","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.vh.2025.08.006_bib0133","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2019.03.012","article-title":"Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine","volume":"1113","author":"Yin","year":"2019","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/bs.vh.2025.08.006_bib0113","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0039-128X(91)90015-N","article-title":"Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism","volume":"56","author":"Yoshiyu","year":"1991","journal-title":"Steroids"},{"key":"10.1016\/bs.vh.2025.08.006_bib0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism:implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0134","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"34","author":"Yozamp","year":"2021","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0136","article-title":"Developing the novel diagnostic model and potential drugs by integrating bioinformatics and machine learning for aldosterone-producing adenomas","author":"Yu","year":"2023","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/bs.vh.2025.08.006_bib0039","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/HYPERTENSIONAHA.124.23379","article-title":"ENaC\u03b3 in urinary extracellular vesicles as an indicator of MR signaling in primary aldosteronism","volume":"81","author":"Yuto","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0137","first-page":"47","article-title":"Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism","author":"Zhang","year":"2025","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/bs.vh.2025.08.006_bib0138","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24580","article-title":"A dilute-and-shoot liquid chromatography\u2013tandem mass spectrometry method for urinary 18-hydroxycortisol quantification and its application in establishing reference intervals","volume":"36","author":"Zhao","year":"2022","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.1016\/bs.vh.2025.08.006_bib0139","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ejendo\/lvae148","article-title":"Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtyping","volume":"191","author":"Zhou","year":"2024","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038489","article-title":"Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/bs.vh.2025.08.006_bib0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jsbmb.2019.01.008","article-title":"Classification of microadenomas in patients with primary aldosteronism by steroid profiling","volume":"189","author":"Yang","year":"2019","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.vh.2025.08.006_bib0129","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/clinem\/dgad010","article-title":"Effect of oral contraception on screening tests for primary aldosteronism: a 10-year longitudinal study","volume":"108","author":"Yang","year":"2023","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Vitamins and Hormones","Primary Aldosteronism: Physiopathology and Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:06:55Z","timestamp":1770052015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431708"],"references-count":139,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.08.006","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}